Fatal cerebro-renal oxalosis after appendectomy

International Journal of Legal Medicine

Volumn 118, Issue 2, 2004, Pages 98-100

  Pfeiffer, H ^a   Weiss, F U ^b   Karger, B ^a   Aghdassi, A ^b   Lerch, M M ^b   Brinkmann, B ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cerebro renal oxalosis; Parenteral nutrition; Xylitol

Indexed keywords

CALCIUM OXALATE; XYLITOL;

ADULT; ANAMNESIS; APPENDECTOMY; ARTICLE; AUTOPSY; BIOACCUMULATION; BRAIN BLOOD VESSEL; BRAIN DYSFUNCTION; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COMA; CRYSTAL; GLUCOSE INFUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY TUBULE; MALE; MINOR SURGERY; NUCLEOTIDE SEQUENCE; OXALOSIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; SEIZURE; SEQUENCE ANALYSIS; SUBENDOTHELIUM;

ADULT; APPENDECTOMY; BRAIN DISEASES; CALCIUM OXALATE; CRYSTALLIZATION; FATAL OUTCOME; HUMANS; KIDNEY FAILURE, ACUTE; MALE; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATIONS; XYLITOL;

EID: 2442551025     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00414-003-0414-3     Document Type: Article

References (18)

1. Alkhunaizi AM, Chan L (1996) Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol 7:2320-2326
2. Aufderheide AC, Dulth M (1971) Renal tubular calcium oxalate crystal depositon. Arch Pathol 92:162-166
3. Bergmann M, Silling-Engelhardt G, Schnabel R, Gulotta F (1991) Therapiebedingte zerebro-renale Oxalose? Z Ges Inn Med 46: 101-106
4. Bundesgesundheitsamt (1990) Fruktoseintoleranz und Dosierungsrichtlinien für Kohlenhydratinfusionen. Bekanntmachung über die Zulassung von Infusionslösungen, pp 2-9
5. Coulter-Mackie MB, Rumsby G, Applegarth DA, Toone JR (2001) Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria. Mol Genet Metabol 74:314-321
6. Dickstein SS, Frame B (1973) Urinary tract calculi after intestinal shunt operation for the treatment of obesity. Surg Gynaecol Obstet 136:257-260
7. Evans GW, Phillips G, Mukherjee TM, Snow MR, Lawrence JR, Thomas DW (1973) Identification of crystal deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods. J Clin Pathol 26: 32-36
8. Frydl V (1987) Zerebrorenale Oxalose - eine metabolische Entgleisung bei parenteralen Infusionen mit Zuckeraustauschstoffen. Zentralbl Allg Pathol Pathol Anat 133:369-376
9. Heye N, Zimmer C, Terstegge K, Sirtl C, Cervos-Navarro J (1991) Oxalate-induced encephalitis after infusions of sugar surrogates. Intensive Care Med 17:432-434
10. Leidig P, Gerding W, Arns W, Ortmann M (2001) Renale Oxalose mit Niereninsuffizienz nach Xylitinfusion. Dtsch Med Wochenschr 126:1357-1360
11. Leumann E, Hoppe B (1991) The primary hyperoxalurias. J Am Soc Nephrol 12:1986-1993
12. Mashour S, Turner JF Jr, Merrell R (2000) Acute renal failure, oxalosis, and vitamin C supplementation - A case report and review of the literature. Chest 118:561-563
13. Mori S, Beppu T (1983) Secondary renal oxalosis. A statistical analysis of its possible causes. Acta Pathol Jpn 33:661-669
14. Nizze H, Schwabbauer P, Brachwitz C, Lange H (1997) Tödliche chronische Oxalose nach sublethaler Äthylenglykolvergiftung. Pathologe 18:328-334
15. Reiter C, Winter RE (1979) Oxalose: Die forensische Bedeutung von Oxalatkristallen in Geweben. Beitr Gerichtl Med 38:441-449
16. Schultze G, Pommer W, Offermann G, Molzahn M, Butz M, Krause PH, Lobeck H, Tschöpe W (1983) Akutes Nierenversagen bei sekundärer renaler Oxalose. Weitere Hinweise auf ursächlichen Zusammenhang mit Xylitinfusion. Infusionstherapie 10:322-328
17. Smith LH, From H, Hoffmann AF (1972) Aquired hyperoxaluria, nephrolithiasis and intestinal disease: description of new symptoms. New Engl J Med 266:1371-1375
18. Thomas DW, Edwards JB, Gilligan JE, Lawrence JR, Edwards RG (1972) Complications following intravenous administration of solutions containing xylitol. Med J Aust 1:1238-1246